Skip to main content
Premium Trial:

Request an Annual Quote

Tecan, Oxford Nanopore Technologies Partner to Automate Nanopore Sequencing Library Prep

NEW YORK – Swiss laboratory automation company Tecan and Oxford Nanopore Technologies said on Monday that they have forged a partnership to automate high-throughput library preparation for nanopore sequencing.

The collaborators will develop “a fully walkaway automated workflow” for Oxford Nanopore’s Ligation Sequencing Kit XL V14 protocol using Tecan’s DreamPrep, an automated next-generation sequencing library prep instrument, the companies said.

Financial and other terms of the agreement were not disclosed.

The partnership further expands Tecan’s portfolio for automated NGS library preparation solutions. Earlier this month, the company signed agreements with Element Biosciences and Singular Genomics to develop automated library prep workflows for their platforms.

“Our collaboration with Tecan is scaling accessible life sciences innovation with a global partner, providing automated seamless plug-and-play solutions to our customers [that will lead to] quicker, higher quality results that save time, cost, and effort,” said Oxford Nanopore CEO Gordon Sanghera in a statement.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.